Antoniou, Tony
Pritlove, Cheryl
Shearer, Dana
Tadrous, Mina
Shah, Hemant
Gomes, Tara
Article History
Received: 6 December 2022
Accepted: 23 May 2023
First Online: 6 June 2023
Change Date: 11 October 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12939-023-02003-4
Declarations
:
: This study was approved by the Research Ethics Board of St. Michael’s Hospital (REB# 18–142). We obtained written informed consent from all participants.
: Not applicable.
: Tony Antoniou has no competing interests. Cheryl Pritlove has no competing interests. Dana Shearer has no competing interests. Mina Tadrous has received consulting fees for unrelated work from Green Shield Canada and the Canadian Agency for Drugs and Technologies in Health. Hemant Shah has received consulting fees from Gilead, Abbvie, Lupin, SRX Health Solutions and Intercept, for unrelated work. Tara Gomes has received funding from the Ontario MOH for unrelated work.